Oct 22, 2020 8:00am EDT Ekso Bionics® to Report Third Quarter 2020 Financial Results on October 29, 2020
Sep 09, 2020 8:00am EDT Ekso Bionics to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on September 16, 2020
Aug 20, 2020 8:30am EDT Ekso Bionics® Unveils its Latest Assistive Exoskeleton Innovation for Industrial Use
Jul 23, 2020 8:00am EDT Ekso Bionics® to Report Second Quarter 2020 Financial Results on July 30, 2020
Jul 09, 2020 8:00am EDT Army Distaff Foundation-Knollwood is First Life Plan Community to Adopt Ekso Bionics’ Exoskeleton Device for Rehabilitation Following Successful Trial
Jun 25, 2020 8:30am EDT Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients
Jun 10, 2020 1:30pm EDT Ekso Bionics Announces Closing of $7.89 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Jun 08, 2020 8:00am EDT Ekso Bionics Announces $7.89 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
